Largest pharmaceuticals by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

AbbVie leads the 35 pharmaceuticals ranked by total debt, at ZAR 1.16T, ahead of Pfizer (ZAR 1.11T) and Merck & Co (ZAR 848B). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
35
First
AbbVieZAR 1.16T
Median
ZAR 90.7B
Combined market value
ZAR 88.5T
Countries
10
Not ranked
26no total debt on file

Market values as of .

Largest pharmaceuticals by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health CareZAR 1.16TZAR 8.87TZAR 5,016.18 0.42% down 26% up United States
2PfizerPFE · Health CareZAR 1.11TZAR 2.79TZAR 489.61 0.02% up 14% up United States
3Merck & CoMRK · Health CareZAR 848BZAR 5.96TZAR 2,418.56 1.95% down 51% up United States
4Johnson & JohnsonJNJ · Health CareZAR 824.6BZAR 11.53TZAR 4,788.28 0.16% down 38% up United States
5Bristol-Myers SquibbBMY · Health CareZAR 775.9BZAR 2.14TZAR 1,048.03 0.73% down 34% up United States
6Eli LillyLLY · Health CareZAR 731.1BZAR 21.71TZAR 24,370.01 0.10% up 35% up United States
7Takeda PharmaceuticalTAK · Health CareZAR 525.9BZAR 1.18TZAR 370.24 0.55% down 54% up Japan
8AstraZenecaAZN · Health CareZAR 509.5BZAR 4.83TZAR 3,111.14 0.74% down 2% up United Kingdom
9NovartisNVS · Health CareZAR 494.2BZAR 5.12TZAR 2,710.11 1.01% down 25% up Switzerland
10SanofiSNY · Health CareZAR 356.9BZAR 1.96TZAR 817.88 0.04% up 4% down France
11Novo NordiskNVO · Health CareZAR 334.3BZAR 3.06TZAR 694.13 0.86% down 17% down Denmark
12GSKGSK · Health CareZAR 330BZAR 1.7TZAR 846.61 0.01% down 6% up United Kingdom
13ViatrisVTRS · Health CareZAR 247.9BZAR 406.1BZAR 354.24 0.71% up 96% up United States
14Abbott LaboratoriesABT · Health CareZAR 222.4BZAR 3.12TZAR 1,800.98 0.05% down 17% down United States
15ZoetisZTS · Health CareZAR 155.5BZAR 587.6BZAR 1,446.05 0.71% up 29% down United States
16Royalty PharmaRPRX · Health CareZAR 154BZAR 680.8BZAR 1,184.08 0.23% up 78% up United States
17Jazz PharmaceuticalsJAZZ · Health CareZAR 92.2BZAR 265.3BZAR 4,133.02 0.18% down 37% up Ireland
18GenmabGMAB · Health CareZAR 90.7BZAR 550.8BZAR 893.22 0.06% down 70% up Denmark
19Elanco Animal HealthELAN · Health CareZAR 69.1BZAR 227.1BZAR 454.27 2.17% up 20% up United States
20Amneal PharmaceuticalsAMRX · Health CareZAR 44.2BZAR 128.3BZAR 368.21 1.36% up 83% up United States
21BridgeBio PharmaBBIO · Health CareZAR 34.5BZAR 258.1BZAR 1,324.78 0.29% up 17% up United States
22Regeneron PharmaceuticalsREGN · Health CareZAR 34.2BZAR 1.72TZAR 16,596.25 0.74% up 36% up United States
23Ionis PharmaceuticalsIONS · Health CareZAR 31.2BZAR 78.8BZAR 473.01 2.00% up 64% down United States
24BeOne MedicinesONC · Health CareZAR 17.7BZAR 804.9BZAR 7,046.36 0.87% down 17% up Switzerland
25Ascendis PharmaASND · Health CareZAR 13.7BZAR 305.8BZAR 4,662.02 0.06% down 28% up Denmark
26InsmedINSM · Health CareZAR 9.4BZAR 460.7BZAR 2,099.84 0.18% up 40% down United States
27Madrigal PharmaceuticalsMDGL · Health CareZAR 5.8BZAR 168BZAR 7,232.47 0.36% down 24% down United States
28Legend BiotechLEGN · Health CareZAR 5.5BZAR 56BZAR 288.80 4.22% up 42% down United States
29CytokineticsCYTK · Health CareZAR 4.9BZAR 124.7BZAR 895.37 0.78% up 20% down United States
30TG TherapeuticsTGTX · Health CareZAR 4.2BZAR 165BZAR 1,091.78 1.22% up 107% up United States
31Cogent BiosciencesCOGT · Health CareZAR 3.8BZAR 84.7BZAR 486.60 1.58% up 20% down United States
32Dr. Reddy's LaboratoriesRDY · Health CareZAR 3.3BZAR 214.2BZAR 256.98 0.95% up 5% up India
33Axsome TherapeuticsAXSM · Health CareZAR 3.2BZAR 123.6BZAR 2,349.93 0.49% up 7% down United States
34Rhythm PharmaceuticalsRYTM · Health CareZAR 1.9BZAR 138.2BZAR 1,993.71 0.60% down 13% up United States
35Definium TherapeuticsDFTX · Health CareZAR 698MZAR 69.4BZAR 506.90 0.31% up 169% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2005 ZAR). 26 companies have no total debt on file and are not ranked here.

Questions and answers

Which pharmaceuticals rank first by total debt?

AbbVie (ZAR 1.16T), Pfizer (ZAR 1.11T) and Merck & Co (ZAR 848B) are the top three of the 35 pharmaceuticals ranked by total debt as of 18 Nov 2026, 14:39 UTC.

How many pharmaceuticals are in this ranking?

35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

The 35 pharmaceuticals ranked by total debt have a combined market value of ZAR 88.5T as of 18 Nov 2026, 14:39 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.